- Home
- IDA vs ICLR Comparison
IDA vs ICLR Comparison
Compare IDA & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IDA | ICLR |
|---|---|---|
| Founded | 1915 | 1990 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 7.1B |
| IPO Year | 1998 | 2001 |
Fundamental Metrics
Financial Performance| Metric | IDA | ICLR |
|---|---|---|
| Price | $140.93 | $94.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | $135.25 | ★ $197.46 |
| AVG Volume (30 Days) | 444.7K | ★ 3.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | ★ 7.00 | N/A |
| EPS | ★ 5.13 | N/A |
| Revenue | ★ $1,768,881,000.00 | N/A |
| Revenue This Year | $7.90 | N/A |
| Revenue Next Year | $8.27 | N/A |
| P/E Ratio | $27.59 | ★ $12.91 |
| Revenue Growth | ★ 7.88 | N/A |
| 52 Week Low | $109.30 | $66.57 |
| 52 Week High | $145.94 | $211.00 |
Technical Indicators
Market Signals| Indicator | IDA | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 68.68 | 26.18 |
| Support Level | $134.31 | $87.91 |
| Resistance Level | $145.94 | $97.30 |
| Average True Range (ATR) | 2.73 | 10.67 |
| MACD | 0.65 | -7.42 |
| Stochastic Oscillator | 72.22 | 23.11 |
Price Performance
Historical ComparisonAbout IDA IDACORP Inc.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.